Hca Healthcare Inc Financials

HCA

Source SEC Filings (10-K/10-Q) Updated Feb 10, 2026 Currency USD FYE February

This page shows Hca Healthcare Inc (HCA) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 12 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Key Financial Metrics

Revenue

$76K

YoY-100.0%

5Y CAGR-93.0%

10Y CAGR-72.3%

Hca Healthcare Inc generated $76K in revenue in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

EBITDA

N/A

Free Cash Flow

$8K

YoY-100.0%

5Y CAGR-92.0%

10Y CAGR-70.9%

Hca Healthcare Inc generated $8K in free cash flow in fiscal year 2025, representing cash available after capex. This represents a decrease of 100.0% from the prior year.

Net Income

$7K

YoY-100.0%

5Y CAGR-92.1%

10Y CAGR-70.1%

Hca Healthcare Inc reported $7K in net income in fiscal year 2025. This represents a decrease of 100.0% from the prior year.

EPS (Diluted)

$28.33

YoY+47.9%

5Y CAGR+36.6%

10Y CAGR+26.2%

Hca Healthcare Inc earned $28.33 per diluted share (EPS) in fiscal year 2025. This represents an increase of 47.9% from the prior year.

Cash & Debt

$1K

YoY-100.0%

5Y CAGR-93.2%

10Y CAGR-72.4%

Hca Healthcare Inc held $1K in cash against $42K in long-term debt as of fiscal year 2025.

Dividends Per Share

$2.40

YoY+7.1%

10Y CAGR-12.8%

Hca Healthcare Inc paid $2.40 per share in dividends in fiscal year 2025. This represents an increase of 7.1% from the prior year.

Shares Outstanding

224M

YoY-19.4%

5Y CAGR-8.6%

10Y CAGR-6.3%

Hca Healthcare Inc had 224M shares outstanding in fiscal year 2025. This represents a decrease of 19.4% from the prior year.

Gross Margin

N/A

Operating Margin

N/A

Net Margin

9.0%

YoY-0.4pp

5Y CAGR+3.9pp

10Y CAGR+4.7pp

Hca Healthcare Inc's net profit margin was 9.0% in fiscal year 2025, showing the share of revenue converted to profit. This is down 0.4 percentage points from the prior year.

Return on Equity

112.6%

Hca Healthcare Inc's ROE was 112.6% in fiscal year 2025, measuring profit generated per dollar of shareholder equity.

R&D Spending

N/A

Share Buybacks

$10K

YoY-100.0%

5Y CAGR-91.3%

Hca Healthcare Inc spent $10K on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding. This represents a decrease of 100.0% from the prior year.

Capital Expenditures

$5K

YoY-100.0%

5Y CAGR-93.0%

10Y CAGR-71.3%

Hca Healthcare Inc invested $5K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents a decrease of 100.0% from the prior year.

HCA Income Statement

Metric	FY25	FY24	FY23	FY20	FY21	FY19
Revenue	$76K-100.0%	$60.2B+2.5%	$58.8B+14.0%	$51.5B+0.4%	$51.3B+17.7%	$43.6B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$548-100.0%	$307.0M-8.9%	$337.0M-19.0%	$416.0M+12.4%	$370.0M+8.8%	$340.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$2K-100.0%	$1.7B+11.2%	$1.6B-1.1%	$1.6B-13.2%	$1.8B+7.9%	$1.7B
Income Tax	$2K-100.0%	$1.7B-17.3%	$2.1B+102.5%	$1.0B-5.1%	$1.1B-32.9%	$1.6B
Net Income	$7K-100.0%	$5.6B-18.9%	$7.0B+85.3%	$3.8B+7.1%	$3.5B+58.2%	$2.2B
EPS (Diluted)	$28.33+47.9%	$19.15-9.5%	$21.16+93.6%	$10.93+8.5%	$10.07+69.2%	$5.95

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'24
Revenue	$19.5B+1.8%	$19.2B+3.0%	$18.6B+1.6%	$18.3B+13.0%	$16.2B+2.2%	$15.9B+1.7%	$15.6B+0.6%	$15.5B
Cost of Revenue	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Gross Profit	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$153.0M+10.1%	$139.0M+6.9%	$130.0M+3.2%	$126.0M+41.6%	$89.0M+8.5%	$82.0M+10.8%	$74.0M-6.3%	$79.0M
Operating Income	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Interest Expense	$572.0M+2.0%	$561.0M-1.2%	$568.0M+3.8%	$547.0M+13.3%	$483.0M-0.4%	$485.0M+1.3%	$479.0M+5.7%	$453.0M
Income Tax	$509.0M-1.2%	$515.0M-1.7%	$524.0M+4.4%	$502.0M+41.4%	$355.0M-10.6%	$397.0M+4.7%	$379.0M-42.2%	$656.0M
Net Income	$1.9B+14.3%	$1.6B-0.6%	$1.7B+2.7%	$1.6B+49.2%	$1.1B-9.6%	$1.2B-12.5%	$1.4B-34.5%	$2.1B
EPS (Diluted)	$8.09+16.2%	$6.96+1.9%	$6.83+5.9%	$6.45+65.0%	$3.91-8.9%	$4.29-11.5%	$4.85-32.6%	$7.20

HCA Balance Sheet

Metric	FY25	FY24	FY23	FY20	FY21	FY19
Total Assets	$61K-100.0%	$52.4B+3.3%	$50.7B+6.8%	$47.5B+5.4%	$45.1B+23.1%	$36.6B
Current Assets	$16K-100.0%	$13.6B+0.7%	$13.5B+9.8%	$12.3B+10.2%	$11.2B+12.2%	$10.0B
Cash & Equivalents	$1K-100.0%	$908.0M-37.4%	$1.5B-19.1%	$1.8B+188.7%	$621.0M-15.2%	$732.0M
Inventory	$2K-100.0%	$2.1B+4.1%	$2.0B-1.9%	$2.0B+9.5%	$1.8B+17.5%	$1.6B
Accounts Receivable	$11K-100.0%	$8.9B+9.8%	$8.1B+14.8%	$7.1B-4.5%	$7.4B+13.5%	$6.5B
Goodwill	$218	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$55K-100.0%	$52.5B+6.6%	$49.3B+10.4%	$44.6B-2.2%	$45.6B+9.7%	$41.6B
Current Liabilities	$16K-100.0%	$9.9B+3.3%	$9.6B+10.1%	$8.7B+12.2%	$7.8B+26.0%	$6.2B
Long-Term Debt	$42K-100.0%	$37.7B+9.8%	$34.3B+11.5%	$30.8B-8.3%	$33.6B+2.2%	$32.9B
Total Equity	$6K+100.0%	-$73.0M-104.9%	$1.5B-48.5%	$2.9B+611.9%	-$565.0M+88.7%	-$5.0B
Retained Earnings	$6K+100.0%	-$2.3B-328.6%	-$532.0M-168.5%	$777.0M+133.0%	-$2.4B+64.0%	-$6.5B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'24
Total Assets	$60.7B+1.6%	$59.7B+0.4%	$59.5B-0.4%	$59.8B+9.5%	$54.6B+1.9%	$53.6B+1.7%	$52.7B+0.5%	$52.4B
Current Assets	$15.8B+3.3%	$15.3B-1.8%	$15.6B-4.3%	$16.3B+13.7%	$14.3B+2.9%	$13.9B+2.6%	$13.5B-0.7%	$13.6B
Cash & Equivalents	$1.0B+4.3%	$997.0M+6.2%	$939.0M-11.4%	$1.1B+19.0%	$891.0M+3.4%	$862.0M+2.4%	$842.0M-7.3%	$908.0M
Inventory	$1.7B-4.7%	$1.7B-3.2%	$1.8B-0.1%	$1.8B-11.6%	$2.0B-1.0%	$2.0B-1.7%	$2.1B+0.8%	$2.1B
Accounts Receivable	$10.9B+4.2%	$10.4B-0.3%	$10.5B-5.7%	$11.1B+20.8%	$9.2B+5.4%	$8.7B+0.6%	$8.7B-2.6%	$8.9B
Goodwill	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$66.7B+2.6%	$65.1B+7.1%	$60.8B+0.9%	$60.2B+11.1%	$54.2B+2.1%	$53.1B+1.2%	$52.5B-0.1%	$52.5B
Current Liabilities	$16.4B-8.6%	$17.9B+12.3%	$15.9B+16.9%	$13.6B+9.9%	$12.4B+7.5%	$11.5B+4.7%	$11.0B+11.4%	$9.9B
Long-Term Debt	$41.6B+8.3%	$38.4B-2.5%	$39.4B-4.1%	$41.1B+11.6%	$36.8B+0.7%	$36.5B+0.2%	$36.5B-3.3%	$37.7B
Total Equity	-$6.0B-13.0%	-$5.3B-330.9%	-$1.2B-182.6%	-$438.0M-222.7%	$357.0M-22.6%	$461.0M+98.7%	$232.0M+417.8%	-$73.0M
Retained Earnings	-$5.7B-14.0%	-$5.0B-22.8%	-$4.1B-29.2%	-$3.2B-59.1%	-$2.0B-7.5%	-$1.9B+8.8%	-$2.0B+11.1%	-$2.3B

HCA Cash Flow Statement

Metric	FY25	FY24	FY23	FY20	FY21	FY19
Operating Cash Flow	$13K-100.0%	$8.5B-4.9%	$9.0B-3.0%	$9.2B+21.4%	$7.6B+40.1%	$5.4B
Capital Expenditures	$5K-100.0%	$4.4B+22.9%	$3.6B+26.2%	$2.8B-31.8%	$4.2B+37.9%	$3.0B
Free Cash Flow	$8K-100.0%	$4.1B-23.3%	$5.4B-15.9%	$6.4B+85.7%	$3.4B+42.8%	$2.4B
Investing Cash Flow	$5K+100.0%	-$3.4B-28.2%	-$2.6B+22.1%	-$3.4B+40.7%	-$5.7B-33.7%	-$4.3B
Financing Cash Flow	$9K+100.0%	-$5.7B+15.0%	-$6.7B-42.3%	-$4.7B-164.1%	-$1.8B-66.9%	-$1.1B
Dividends Paid	$679-100.0%	$653.0M+4.6%	$624.0M+307.8%	$153.0M-72.2%	$550.0M	$0
Share Buybacks	$10K-100.0%	$7.0B-14.8%	$8.2B+1762.8%	$441.0M-57.2%	$1.0B-49.7%	$2.1B

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'24
Operating Cash Flow	N/A	N/A	N/A	$1.7B	N/A	N/A	$1.8B	N/A
Capital Expenditures	N/A	N/A	N/A	$991.0M	N/A	N/A	$1.2B	N/A
Free Cash Flow	N/A	N/A	N/A	$660.0M	N/A	N/A	$606.0M	N/A
Investing Cash Flow	N/A	N/A	N/A	-$1.0B	N/A	N/A	-$1.2B	N/A
Financing Cash Flow	N/A	N/A	N/A	-$1.5B	N/A	N/A	-$725.0M	N/A
Dividends Paid	N/A	N/A	N/A	$180.0M	N/A	N/A	$175.0M	N/A
Share Buybacks	N/A	N/A	N/A	$2.5B	N/A	N/A	$846.0M	N/A

HCA Financial Ratios

Metric	FY25	FY24	FY23	FY20	FY21	FY19
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	9.0%-0.4pp	9.4%-2.5pp	11.8%+4.6pp	7.3%+0.5pp	6.8%+1.8pp	5.1%
Return on Equity	112.6%	N/A	467.2%+337.4pp	129.8%	N/A	N/A
Return on Assets	11.2%+0.4pp	10.8%-2.9pp	13.7%+5.8pp	7.9%+0.1pp	7.8%+1.7pp	6.1%
Current Ratio	0.97-0.4	1.38-0.0	1.410.0	1.42-0.0	1.44-0.2	1.62
Debt-to-Equity	6.90+523.5	-516.63-539.7	23.06+12.4	10.65+70.1	-59.43-52.9	-6.58
FCF Margin	10.2%+3.3pp	6.9%-2.3pp	9.2%-3.3pp	12.4%+5.7pp	6.7%+1.2pp	5.5%

Metric	Q4'25	Q3'25	Q2'25	Q1'25	Q3'24	Q2'24	Q1'24	Q4'24
Gross Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Operating Margin	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Net Margin	9.6%+1.0pp	8.6%-0.3pp	8.9%+0.1pp	8.8%+2.1pp	6.7%-0.9pp	7.5%-1.2pp	8.7%-4.7pp	13.4%
Return on Equity	151.6%-10.0pp	161.6%+52.5pp	109.1%-16.2pp	125.3%-177.0pp	302.2%+43.5pp	258.8%-328.7pp	587.5%	N/A
Return on Assets	3.1%+0.3pp	2.8%-0.0pp	2.8%+0.1pp	2.7%+0.7pp	2.0%-0.2pp	2.2%-0.4pp	2.6%-1.4pp	4.0%
Current Ratio	0.97+0.1	0.85-0.1	0.98-0.2	1.19+0.0	1.15-0.1	1.20-0.0	1.23-0.1	1.38
Debt-to-Equity	-6.90+0.3	-7.20+24.6	-31.81+61.9	-93.74-196.8	103.06+23.8	79.26-78.0	157.23+673.9	-516.63
FCF Margin	N/A	N/A	N/A	3.6%	N/A	N/A	3.9%	N/A

Note: The current ratio is below 1.0 (0.97), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Financial Health Signals

Financial Profile 34/100

Profitability

N/A

Growth

Leverage

Liquidity

Cash Flow

Returns

100

Based on FY2025 annual data. Scores normalized against common benchmarks.

Piotroski F-Score Strong

7/9

Financial strength trend (9 signals). 7-9 = strong, 0-3 = weak.

Earnings Quality Cash-Backed

1.86x

Operating cash flow vs net income. Above 1.0x = cash-backed earnings.

Similar Companies

Tenet Healthcare Corp THC

$20.4B

Univ Health Svc UHS

$14.6B

Fresenius Med Cr FMS

$14.2B

Encompass Health Corp EHC

$11.2B

Ensign Group Inc ENSG

$12.5B

Frequently Asked Questions

What is Hca Healthcare Inc's annual revenue?

Hca Healthcare Inc (HCA) reported $76K in total revenue for fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Hca Healthcare Inc's revenue growing?

Hca Healthcare Inc (HCA) revenue declined by 100% year-over-year, from $60.2B to $76K in fiscal year 2025.

Is Hca Healthcare Inc profitable?

Yes, Hca Healthcare Inc (HCA) reported a net income of $7K in fiscal year 2025, with a net profit margin of 9.0%.

What is Hca Healthcare Inc's earnings per share (EPS)?

Hca Healthcare Inc (HCA) reported diluted earnings per share of $28.33 for fiscal year 2025. This represents a 47.9% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

How much debt does Hca Healthcare Inc have?

As of fiscal year 2025, Hca Healthcare Inc (HCA) had $1K in cash and equivalents against $42K in long-term debt.

What is Hca Healthcare Inc's net profit margin?

Hca Healthcare Inc (HCA) had a net profit margin of 9.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Does Hca Healthcare Inc pay dividends?

Yes, Hca Healthcare Inc (HCA) paid $2.40 per share in dividends during fiscal year 2025.

What is Hca Healthcare Inc's return on equity (ROE)?

Hca Healthcare Inc (HCA) has a return on equity of 112.6% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Hca Healthcare Inc's free cash flow?

Hca Healthcare Inc (HCA) generated $8K in free cash flow during fiscal year 2025. This represents a -100.0% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Hca Healthcare Inc's operating cash flow?

Hca Healthcare Inc (HCA) generated $13K in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Hca Healthcare Inc's total assets?

Hca Healthcare Inc (HCA) had $61K in total assets as of fiscal year 2025, including both current and long-term assets.

What are Hca Healthcare Inc's capital expenditures?

Hca Healthcare Inc (HCA) invested $5K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Does Hca Healthcare Inc buy back shares?

Yes, Hca Healthcare Inc (HCA) spent $10K on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Hca Healthcare Inc have outstanding?

Hca Healthcare Inc (HCA) had 224M shares outstanding as of fiscal year 2025.

What is Hca Healthcare Inc's current ratio?

Hca Healthcare Inc (HCA) had a current ratio of 0.97 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Hca Healthcare Inc's debt-to-equity ratio?

Hca Healthcare Inc (HCA) had a debt-to-equity ratio of 6.90 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Hca Healthcare Inc's return on assets (ROA)?

Hca Healthcare Inc (HCA) had a return on assets of 11.2% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Hca Healthcare Inc's Piotroski F-Score?

Hca Healthcare Inc (HCA) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals.

Are Hca Healthcare Inc's earnings high quality?

Hca Healthcare Inc (HCA) has an earnings quality ratio of 1.86x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation.

How financially healthy is Hca Healthcare Inc?

Hca Healthcare Inc (HCA) scores 34 out of 100 on our Financial Profile, indicating weak overall financial health. This composite score evaluates six dimensions: profitability (operating margin), revenue growth, leverage (debt-to-equity), liquidity (current ratio), cash flow quality (free cash flow margin), and shareholder returns (return on equity). Each dimension is normalized against standard financial benchmarks.